Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

NCT03869814 is registered in ClinicalTrials.gov with ClearNote Health as lead sponsor.

NCT NCT03869814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
Lead sponsor
ClearNote Health
Phase
Observational
Overall status
Recruiting
Start date
April 5, 2018
Completion date
September 13, 2029
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis of cancer of various organs